Warp Sciences, co-founded by OpenAI's former CPO and VP of Science, raised a $215M Series A led by Lightspeed to apply AI and robotics to drug development. Co-founders include DJ Patil, FAIR co-founder Manohar Paluri, and drug hunter Sol Reisberg. The company is building a next-generation preclinical CRO in the US, making and testing molecules for drug developers rather than developing its own drugs. The author cites reshoring scientific capability from Chinese CROs like Wuxi and a data flywheel: robots run experiments that train AI models, which in turn improve the labs. Investors include PremjiInvest, IVP, Mayfield, Lux Capital, and Coinbase's Brian Armstrong as an angel.

AI summary of the linked source — not editorial content.

Story signal · how it spread on X · via Elfa

as of
Spread
i
Distinct X and Telegram accounts Elfa counted behind this story’s reports, summed over the thread. Not posts, not impressions.
7 accounts

first post
Leviathan +32.6 h later

OPENAI reaction
i
Price change from the first post to 24 hours later (Hyperliquid). BTC over the same window is shown so a market-wide move is not mistaken for a reaction to this story. Not advice.
−2.9% 24h after post

$1,528 → $1,483
BTC +0.1% same window

Thread · 1 event
  1. First reportFormer OpenAI science head Kevin Weil launches Warp Sciences with $215 million7 acc.
  2. Leviathan published this article

All times UTC.

Cited posts

  • @RebeccaTorrenc5 Rebecca TorrenceFirst reportOn X ↗

    Exclusive: OpenAI's former AI-for-science head is launching a new startup with $215 million in funding. Kevin Weil's Warp Sciences wants to build a fully robotic laboratory to automate a key step in drug development that pharma companies have long outsourced to China.👇

  • @business BloombergOn X ↗

    Ex-OpenAI science head Kevin Weil launches startup with $215 million https://t.co/mTAKSv4Mze

  • @TheRundownAI The Rundown AIOn X ↗

    NEW: Ex-OpenAI product chief Kevin Weil raised $215M for Warp Sciences, which is building labs where AI designs experiments and robots run them 24/7. The startup is focused on drug discovery first, with the overarching goal of "scientific superintelligence."

Show 3 more cited posts
  • @metavestorOn X ↗

    ex-Chief Product Officer at OpenAI, Kevin Weil, has raised a $215 series A for Warp Sciences robotic labs "Robotic labs will let us do science at massive scale—and generate the data to train amazing AI models for science." Eyes open, this is where the puck is heading! https://t.co/sM9A8wgGUb

  • @AndrewCurran_ Andrew CurranOn X ↗

    Lieutenant Colonel Kevin Weil emerging from stealth with $215m in funding from a Series A! Warp Sciences is using AI and robots to make and test molecules for companies developing new drugs. He was OpenAI CPO, and was leading AI-for-science before he left to found Warp. https://t.co/8oMWV9IXox

  • @MTSlive MTSOn X ↗

    SITUATION DETECTED: Former OpenAI CPO Kevin Weil has launched his startup Warp Sciences from stealth with $215 million in funding. The company is building AI and robotics-powered labs to accelerate drug discovery.

1 more account posted about this

TradersTrader calls tracked by Elfa · not advice

Positioning · OPENAI

Open70 open positions · 59 long · 11 short

Tracked accounts lean long about 97% of the time, so a long-heavy book is normal, not a signal. As of 23 Oct 19:51 UTC.

Reaction since the first post

Since 22 Oct 15:34 UTC2 calls opened · 0 long · 2 short

Whole crypto market, not this story

Crowding8th percentile · vs last 28 days, 50 typical
Pulse 24h19/100 · unusualness of new calls, 0–100, 50 typical, higher means more long than usual
Book97.3% long · 10,911 accounts

As of 24 Oct 00:00 UTC.

Social-monitoring data, not investment advice Elfa prices Hyperliquid post text from Xas of

Explore the topic

Loading related coverage…

Explore the full feed

Comments

Loading comments…